Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Wan-Teck Lim

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2023
Is There a Unicorn Among the Uncommon EGFR Mutations?Wan Ling Tan, Darren Wan-Teck Lim
Annals of the Academy of Medicine, Singapore|January 5, 2022
The case for better hospitalisation selection in cancer patientsDarren Wan Teck Lim, Quan Sing Ng
JTO Clinical and Research Reports|June 12, 2023
Diverse Resistant Mechanisms Identified Using Serial Next-Generation Sequencing in a Patient With ALK-Rearranged Metastatic Lung Adenocarcinoma: A Case ReportStephanie Pei Li Saw, Darren Wan-Teck Lim
Translational Oncology|May 28, 2026
Therapeutic vaccines targeting solid tumors: A series of clinical trial analysis over the past decadeFengqi Qiu, Yilan Sun, Darren Wan-Teck Lim
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 4, 2021
Bacillus Calmette-Guérin scar flare after an mRNA SARS-CoV-2 vaccineDarren Wan-Teck Lim, Dorothy Hui Lin Ng, Jenny Guek-Hong Low
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 19, 2021
Darren Wan-Teck Lim, Dorothy Hui Lin Ng, Jenny Guek-Hong Low
Therapeutic Advances in Medical Oncology|April 26, 2019
First-line afatinib for the treatment of <i>EGFR</i> mutation-positive non-small-cell lung cancer in the 'real-world' clinical settingKeunchil Park, Darren Wan-Teck Lim, Isamu Okamoto, et al.
Biomedicines|February 25, 2023
Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLCKah Yee Goh, Terence You De Cheng, Su Chin Tham, et al.
Biomedicines|August 28, 2025
Novel Therapeutic Strategies for Squamous Cell Carcinoma of the Head and Neck: Beyond EGFR and Checkpoint BlockadeRachel Hui Zhen Sim, Pei Jye Voon, Seng Wee Cheo, et al.
Cancer Treatment Reviews|April 19, 2025
Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherapyMakoto Tahara, Darren Wan-Teck Lim, Bhumsuk Keam, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2023
Is There a Unicorn Among the Uncommon EGFR Mutations?Wan Ling Tan, Darren Wan-Teck Lim
Annals of the Academy of Medicine, Singapore|January 5, 2022
The case for better hospitalisation selection in cancer patientsDarren Wan Teck Lim, Quan Sing Ng
JTO Clinical and Research Reports|June 12, 2023
Diverse Resistant Mechanisms Identified Using Serial Next-Generation Sequencing in a Patient With ALK-Rearranged Metastatic Lung Adenocarcinoma: A Case ReportStephanie Pei Li Saw, Darren Wan-Teck Lim
Translational Oncology|May 28, 2026
Therapeutic vaccines targeting solid tumors: A series of clinical trial analysis over the past decadeFengqi Qiu, Yilan Sun, Darren Wan-Teck Lim
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 4, 2021
Bacillus Calmette-Guérin scar flare after an mRNA SARS-CoV-2 vaccineDarren Wan-Teck Lim, Dorothy Hui Lin Ng, Jenny Guek-Hong Low
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 19, 2021
Darren Wan-Teck Lim, Dorothy Hui Lin Ng, Jenny Guek-Hong Low
Therapeutic Advances in Medical Oncology|April 26, 2019
First-line afatinib for the treatment of <i>EGFR</i> mutation-positive non-small-cell lung cancer in the 'real-world' clinical settingKeunchil Park, Darren Wan-Teck Lim, Isamu Okamoto, et al.
Biomedicines|February 25, 2023
Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLCKah Yee Goh, Terence You De Cheng, Su Chin Tham, et al.
Biomedicines|August 28, 2025
Novel Therapeutic Strategies for Squamous Cell Carcinoma of the Head and Neck: Beyond EGFR and Checkpoint BlockadeRachel Hui Zhen Sim, Pei Jye Voon, Seng Wee Cheo, et al.
Cancer Treatment Reviews|April 19, 2025
Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherapyMakoto Tahara, Darren Wan-Teck Lim, Bhumsuk Keam, et al.
Pageof 5